How might Trump’s IRA rollback affect Medicare drug costs?

Trump’s proposed rollback of the Inflation Reduction Act (IRA) could lead to increased drug prices for Medicare beneficiaries. The IRA currently allows Medicare to negotiate prices for certain drugs, providing relief to patients by lowering out-of-pocket costs. If this provision is rolled back, pharmaceutical companies may not face price restrictions, which could result in higher drug prices for Medicare recipients. The move could shift the balance between fostering innovation in the pharmaceutical industry and maintaining affordable healthcare for seniors. For more details, visit https://issueinside.blogspot.com/2025/01/ira-rollback-and-pbm-transparency.html

IRA Rollback and PBM Transparency: Trump’s Pharma Vision